Skip to content

Effect of telerehabilitation versus supervised physiotherapy on frailty in older adults: a randomized controlled trial

Design, validate and evaluate the effectiveness of telerehabilitation-based verses therapist-supervised multimodal physiotherapeutic intervention on biopsychosocial domains of frailty in elderly population: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110882
Enrollment
116
Registered
2026-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Telerehabilitation-based Multimodal Physiotherapeutic Intervention: Participants will undergo a 6-week telerehabilitation program via supervised online physiotherapy sessions. Exercises

Sponsors

Delhi Pharmaceutical Science and Research University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Community-dwelling or institutionalized older adults. 2. Edmonton Frail Scale score of 8 or higher (Screening tool). 3. Mild cognitive impairment- MoCA score of 18-25 (Screening tool). 4. Presence of stable, managed chronic conditions (e.g., diabetes, hypertension, thyroid) . 5. Adequate vision and hearing with or without aids permitted. 6. Access to digital technology and internet. 7. Able to read and understand English

Exclusion criteria

Exclusion criteria: 1. Participants with moderate to severe cognitive impairment (screened using Trail Making Test), dementia or Alzheimer s disease 2. Acute illness or infection at assessment 3. Use of anti-inflammatory or immunosuppressive medications (including corticosteroids or immunomodulators) 4. Currently engaged in structured exercise programs or very high physical activity ( more than 5 hours per week) 5. Severe psychiatric disorders (schizophrenia, bipolar disorder, severe depression) 6. Unstable vital signs (blood pressure, heart rate, respiratory rate, oxygen saturation) 7. History of trauma or surgery within the past 6 months 8. Bedbound status or severe mobility limitations with or without assistance 9. Current malignancy or undergoing chemotherapy or radiotherapy 10. History of seizures or major neurological disorders (such as Parkinson s disease or stroke) 11. Inability to understand study instructions due to language barriers will be excluded.

Design outcomes

Primary

MeasureTime frame
1. Physical frailty by [Clinical frailty scale and Short Physical Performance Battery (SPPB)] 2. Cognitive frailty by [Montreal Cognitive Assessment (MoCA)] 3. Psychological frailty by [Tilburg Frailty Indicator (TFI)- Psychological frailty domain] 4. Social Frailty [Social Frailty Scale (SFS-8)]Timepoint: Baseline (before the start of intervention) On the last day of week 3 On the last day of week 6

Secondary

MeasureTime frame
1. Inflammatory biomarkers of frailty by blood CRP levels. 2. Sleep quality by Pittsburgh Sleep Quality Index (PSQI) 3. Quality of life by Older People s Quality of Life (Brief)-OPQOL-BREF Timepoint: Baseline (before the start of intervention) On the last day of week 3 On the last day of week 6

Countries

India

Contacts

Public ContactDr Sheetal Kalra

Delhi Pharmaceutical Science and Research University

nitikaroy95@gmail.com8447617085

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026